Genome-Wide Screening of mRNA Expression in Leprosy Patients

Area of Science:

• Infectious Diseases
• Molecular Biology
• Genomics

Background:

• Leprosy, caused by Mycobacterium leprae, affects millions globally.
• Molecular mechanisms of leprosy pathogenesis remain poorly understood.
• Understanding gene expression in leprosy is crucial for advancing diagnostics and therapeutics.

Purpose of the Study:

• To comprehensively assess human mRNA expression in leprosy skin lesions.
• To identify differentially expressed genes across the disease spectrum and reactional states.
• To uncover potential molecular markers for leprosy diagnosis and treatment.

Main Methods:

• Utilized DNA chip microarrays for human mRNA profiling.
• Analyzed 66 leprosy lesion samples and 9 healthy control skin biopsies.
• Identified differentially expressed mRNAs with a fold change (FC) ≥ 2.0 and p ≤ 0.05.

Main Results:

• Identified 1580 differentially expressed mRNAs in leprosy lesions compared to controls.
• Discovered genes common to all leprosy forms (e.g., CD2, MMP9) and reaction-specific genes (e.g., IL1B, PTX3).
• Highlighted the involvement of these mRNAs in various pathophysiological processes and signaling pathways.

Conclusions:

• The identified differentially expressed mRNAs represent key molecular players in leprosy.
• These genes hold promise as diagnostic markers for leprosy.
• Further research into these mRNAs could lead to novel therapeutic targets for leprosy.